Shivbrat Upadhyay
Overview
Explore the profile of Shivbrat Upadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khan M, Khan Z, Husain I, Upadhyay S, Zehra S, Ahmad R
PLoS One
. 2025 Feb;
20(2):e0311685.
PMID: 39999029
Intense cancer research is underway to discover possible therapies but no major breakthrough appears to be in sight in terms of its cure when diagnosed late. The cytostatic and growth...
2.
Upadhyay S, Ahmad R, Kumar R, Ghildiyal S, Singh A, Ahmad K, et al.
J Tradit Complement Med
. 2025 Jan;
14(6):644-655.
PMID: 39850602
Background And Aim: L. has been used medicinally and traditionally since antiquity. This study sought to examine the ethanolic extract (ASEE) in inducing apoptosis in human triple-negative breast cancer (TNBC)...
3.
Srivastava A, Ahmad R, Wani I, Siddiqui S, Yadav K, Trivedi A, et al.
In Silico Pharmacol
. 2024 Feb;
12(1):14.
PMID: 38419919
Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-023-00184-y.
4.
Tiwari R, Ghildiyal S, Gaur P, Fatima T, Upadhyay S, Srivastva J, et al.
J Vector Borne Dis
. 2023 Apr;
60(1):65-73.
PMID: 37026221
Background & Objectives: Japanese encephalitis virus (JEV) is one of the most important causes of acute and uncontrolled inflammatory disease in Asia. Matrix metalloproteinases (MMPs) and chemokines play a detrimental...
5.
Siddiqui S, Upadhyay S, Ahmad R, Abul Barkat M, Jamal A, Alothaim A, et al.
Appl Biochem Biotechnol
. 2022 Jul;
194(12):5918-5944.
PMID: 35838886
Novel SARS-CoV-2 claimed a large number of human lives. The main proteins for viral entry into host cells are SARS-CoV-2 spike glycoprotein (PDB ID: 6VYB) and spike receptor-binding domain bound...
6.
Husain I, Ahmad R, Siddiqui S, Chandra A, Misra A, Srivastava A, et al.
J Food Biochem
. 2022 Jul;
46(10):e14262.
PMID: 35796388
SARS-CoV-2 has been responsible for causing 6,218,308 deaths globally till date and has garnered worldwide attention. The lack of effective preventive and therapeutic drugs against SARS-CoV-2 has further worsened the...
7.
Khan M, Singh R, Siddiqui S, Ahmad I, Ahmad R, Upadhyay S, et al.
BMC Complement Med Ther
. 2022 Mar;
22(1):68.
PMID: 35291987
Background: Phoenix dactylifera L. has a diverse set of pharmacological properties due to its distinct phytochemical profile. The purpose of this study was to investigate the anticancer potential of Phoenix...
8.
Baluni M, Ghildiyal S, Fatima T, Tiwari R, Upadhyay S, Dhole T, et al.
J Med Virol
. 2021 Oct;
94(2):531-539.
PMID: 34698413
Japanese encephalitis is one of the serious vector-borne viral encephalitis diseases found worldwide and poses a major threat to public health. Most Japanese encephalitis virus (JEV) infections are subclinical; only...
9.
Ghildiyal S, Fatima T, Singh D, Upadhyay S, Dhole T, Reddy D, et al.
Cytokine
. 2021 Oct;
149:155716.
PMID: 34634652
Background: Japanese encephalitis virus (JEV) is the major cause of viral encephalitis in many regions of Asia. Cytokines, including pro-inflammatory and anti-inflammatory are key regulators playing a detrimental role in...
10.
Trivedi A, Ahmad R, Siddiqui S, Misra A, Khan M, Srivastava A, et al.
J Biomol Struct Dyn
. 2021 Jul;
40(20):9648-9700.
PMID: 34243689
There is currently a dearth of specific therapies to treat respiratory infections caused by the three related species of coronaviruses . SARS-CoV-2, SARS-CoV and MERS-CoV. Prevention from disease is currently...